D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 103 Citations 34,474 429 World Ranking 3278 National Ranking 133

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are Pathology, Cancer, Metastasis, Circulating tumor cell and Bone marrow. His studies in Pathology integrate themes in fields like Breast cancer and Primary tumor. In Cancer, Klaus Pantel works on issues like Disease, which are connected to Personalized medicine and Tumor microenvironment.

His work carried out in the field of Metastasis brings together such families of science as Extracellular matrix, Epithelial cell adhesion molecule, Lung and Monoclonal antibody. The various areas that he examines in his Circulating tumor cell study include Peripheral blood, Cancer research, Colorectal cancer and Oncology. His research integrates issues of Adjuvant therapy, Disseminated Tumor Cell, Antigen and Micrometastasis in his study of Bone marrow.

His most cited work include:

  • Tumour exosome integrins determine organotropic metastasis (2046 citations)
  • Cell-free nucleic acids as biomarkers in cancer patients (1731 citations)
  • A pooled analysis of bone marrow micrometastasis in breast cancer (1067 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Oncology, Pathology, Circulating tumor cell and Cancer. Klaus Pantel combines subjects such as Esophageal cancer, Clinical significance, Proportional hazards model, Biomarker and Prospective cohort study with his study of Oncology. Klaus Pantel interconnects Primary tumor and Metastasis in the investigation of issues within Pathology.

Klaus Pantel has included themes like Liquid biopsy, Colorectal cancer, Clinical trial and Peripheral blood in his Circulating tumor cell study. His research in Cancer intersects with topics in Cancer research, Lung cancer and Minimal residual disease. The concepts of his Breast cancer study are interwoven with issues in Immunohistochemistry and Surgical oncology.

He most often published in these fields:

  • Internal medicine (43.64%)
  • Oncology (39.97%)
  • Pathology (38.28%)

What were the highlights of his more recent work (between 2016-2021)?

  • Circulating tumor cell (36.72%)
  • Internal medicine (43.64%)
  • Cancer research (28.81%)

In recent papers he was focusing on the following fields of study:

Klaus Pantel mainly investigates Circulating tumor cell, Internal medicine, Cancer research, Oncology and Cancer. His Circulating tumor cell research integrates issues from Clinical trial, Chemotherapy, Liquid biopsy, Breast cancer and Primary tumor. His Cancer research study combines topics in areas such as Bladder cancer, Cystectomy, Metastasis, Prostate cancer and Bone marrow.

His Bone marrow study incorporates themes from Haematopoiesis and Bone metastasis. His Oncology study integrates concerns from other disciplines, such as Prospective cohort study, Metastatic breast cancer, Proportional hazards model and Trastuzumab. The Cancer study combines topics in areas such as Carcinoma, Pathology, Minimal residual disease and microRNA.

Between 2016 and 2021, his most popular works were:

  • Liquid Biopsies, What We Do Not Know (Yet). (238 citations)
  • Liquid biopsy and minimal residual disease - latest advances and implications for cure. (224 citations)
  • Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. (191 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Klaus Pantel spends much of his time researching Circulating tumor cell, Cancer research, Internal medicine, Oncology and Cancer. His Circulating tumor cell research is multidisciplinary, incorporating perspectives in Chemotherapy, Lung cancer, Pathology, Liquid biopsy and Hazard ratio. His Pathology research incorporates elements of Cancer stem cell and Primary tumor.

His Cancer research research includes themes of Epithelial–mesenchymal transition, Metastasis, Cell, Clinical significance and Carcinoma. His Oncology research is multidisciplinary, relying on both Survival analysis, Metastatic breast cancer, Proportional hazards model and Clinical trial. The study incorporates disciplines such as Immune system and Bone marrow, Minimal residual disease in addition to Cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cell-free nucleic acids as biomarkers in cancer patients

Heidi Schwarzenbach;Dave S. B. Hoon;Klaus Pantel.
Nature Reviews Cancer (2011)

2797 Citations

Tumour exosome integrins determine organotropic metastasis

Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues.
Nature (2015)

2595 Citations

Dissecting the metastatic cascade

Klaus Pantel;Ruud H. Brakenhoff.
Nature Reviews Cancer (2004)

1647 Citations

In vitro differentiation of endothelial cells from AC133-positive progenitor cells

Ursula M. Gehling;Süleyman Ergün;Udo Schumacher;Christoph Wagener.
Blood (2000)

1433 Citations

A pooled analysis of bone marrow micrometastasis in breast cancer

Stephan Braun;Florian D. Vogl;Bjørn Naume;Wolfgang Janni.
The New England Journal of Medicine (2005)

1432 Citations

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

Stephan Braun;Klaus Pantel;Peter Müller;Wolfgang Janni.
The New England Journal of Medicine (2000)

1330 Citations

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Sabine Riethdorf;Herbert Fritsche;Volkmar Müller;Thomas Rau.
Clinical Cancer Research (2007)

1325 Citations

Detection, clinical relevance and specific biological properties of disseminating tumour cells

Klaus Pantel;Ruud H. Brakenhoff;Burkhard Brandt.
Nature Reviews Cancer (2008)

1254 Citations

Challenges in circulating tumour cell research.

Catherine Alix-Panabières;Klaus Pantel.
Nature Reviews Cancer (2014)

1221 Citations

Circulating Tumor Cells: Liquid Biopsy of Cancer

Catherine Alix-Panabières;Klaus Pantel.
Clinical Chemistry (2013)

1051 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Klaus Pantel

Ronald Simon

Ronald Simon

Universität Hamburg

Publications: 110

Massimo Cristofanilli

Massimo Cristofanilli

Northwestern University

Publications: 99

Thorsten Schlomm

Thorsten Schlomm

Universität Hamburg

Publications: 85

Jakob R. Izbicki

Jakob R. Izbicki

Universität Hamburg

Publications: 81

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 74

Hartwig Huland

Hartwig Huland

Universität Hamburg

Publications: 65

Daniel A. Haber

Daniel A. Haber

Harvard University

Publications: 59

Chwee Teck Lim

Chwee Teck Lim

National University of Singapore

Publications: 54

Dave S.B. Hoon

Dave S.B. Hoon

St. John's University

Publications: 53

Caroline Dive

Caroline Dive

University of Manchester

Publications: 52

Erik W. Thompson

Erik W. Thompson

Queensland University of Technology

Publications: 51

Mehmet Toner

Mehmet Toner

Harvard University

Publications: 46

Kenneth J. Pienta

Kenneth J. Pienta

Johns Hopkins University School of Medicine

Publications: 45

Yibin Kang

Yibin Kang

Princeton University

Publications: 44

Michael R. Speicher

Michael R. Speicher

Medical University of Graz

Publications: 44

George A. Calin

George A. Calin

The University of Texas MD Anderson Cancer Center

Publications: 41

Something went wrong. Please try again later.